0.120High0.120Low95.00KVolume0.120Open0.125Pre Close11.40KTurnover0.15052wk High0.00%Turnover Ratio0Shares0.11552wk Low--EPS TTM0Float Cap0.150Historical High--P/E (Static)0Shs Float0.115Historical Low--EPS LYR0.00%Amplitude--Dividend TTM--P/B100Lot Size--Div YieldTTM
Resistance: RM0.335, RM0.350
Selling pressure on SUNZEN had tested the RM0.305 region, which had since rebounded strongly to the current RM0.330 level. We see a potential upward movement to challenge the RM0.335 and RM0.350 levels ahead, indicating a strong buying interest piqued by successful support level tests. Remain BUY for SUNZEN ahead.
$SUNZEN (0148.BMS)$
I heard that the bird’s nest farming industry is under pressure, with the price of the highest quality bird’s nests dropping from RM3300/kg in April to RM2400. This is reportedly due to crackdowns on smuggling by Chinese customs. Processing costs for bird’s nests have decreased by 25%. Assuming an export volume of 2600 kg over three months, Sunzen’s profits for June to September could theoretically increase by RM2 million. Additionally, the animal division has saved a mill...
Time for some news to trigger the spike, perhaps the QR?
After the closure of the animal health department, how will these two properties, be handled? The report shows the valuation price in 2018, and now the property prices have increased even further. will they sell the property and inject the money to finsource or use it for M&A?
2.6% of cw has been converted to ordinary shares in 2 months, bringing RM 1.9million cash to sunzen. the intention to reach 500 million capital is very obvious, they will use this money to carry another M&A , since floating cw getting lesser, i guess cw will move faster in the future.
Support: RM0.345, RM0.320
Resistance: RM0.350, RM0.370
$SUNZEN (0148.BMS)$
Sunzen Biotech Berhad has undergone significant business transformation and growth in recent years. Here are some key investment highlights to help you better understand the future prospects of this company.
Exiting from Animal Health Business. As of the latest record (FY2022), the animal health business accounted for 6.01% of the annual revenue but incurred a pre-tax loss of RM4.67 millio...
they not only want more M&A,they want the best M&A. they will be more famous,benefit ecolite brands ,attract more investor
maybe is time to add some cw,is going to be dinosour soon
they try very hard to expand nosh to reach bursa requirement?more than 2% cw had converted to ordianaryshares
No comment yet